Follow
Sada Soorapanth
Sada Soorapanth
Professor of Decision Sciences, San Francisco State University
Verified email at sfsu.edu
Title
Cited by
Cited by
Year
Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness
K Desai, SL Sansom, ML Ackers, SR Stewart, HI Hall, DJ Hu, R Sanders, ...
Aids 22 (14), 1829-1839, 2008
1972008
Cost-effectiveness of HIV rescreening during late pregnancy to prevent mother-to-child HIV transmission in South Africa and other resource-limited settings
S Soorapanth, S Sansom, M Bulterys, M Besser, G Theron, MG Fowler
JAIDS Journal of Acquired Immune Deficiency Syndromes 42 (2), 213-221, 2006
592006
Cost-effectiveness of HIV screening in STD clinics, emergency departments, and inpatient units: a model-based analysis
VS Prabhu, PG Farnham, AB Hutchinson, S Soorapanth, JD Heffelfinger, ...
PLoS One 6 (5), e19936, 2011
522011
A Lagrangian relaxation based approach to schedule asset overhaul and repair services
PB Luh, D Yu, S Soorapanth, AI Khibnik, R Rajamani
IEEE Transactions on Automation Science and Engineering 2 (2), 145-157, 2005
512005
Infection transmission system models for microbial risk assessment
SE Chick, JS Koopman, S Soorapanth, ME Brown
Science of the Total Environment 274 (1-3), 197-207, 2001
372001
Inferring infection transmission parameters that influence water treatment decisions
SE Chick, S Soorapanth, JS Koopman
Management Science 49 (7), 920-935, 2003
322003
Updated estimates of healthcare utilization and costs among perinatally HIV-infected children
SL Sansom, JE Anderson, PG Farnham, K Dominguez, S Soorapanth, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 41 (4), 521-526, 2006
262006
Rural–urban differences in vaccination and hesitancy rates and trust: US COVID-19 trends and impact survey on a social media platform, may 2021–April 2022
S Soorapanth, R Cheung, X Zhang, AH Mokdad, GA Mensah
American Journal of Public Health 113 (6), 680-688, 2023
182023
Assessing the value of modelling and simulation in health care: An example based on increasing access to stroke treatment
S Soorapanth, T Young
Journal of the Operational Research Society 70 (2), 226-236, 2019
112019
The costs and value of modelling-based design in healthcare delivery: Five case studies from the US
T Young, S Soorapanth, J Wilkerson, L Millburg, T Roberts, ...
Health Systems 9 (3), 253-262, 2020
102020
Evaluating the financial impact of modeling and simulation in healthcare: Proposed framework with a case study
S Soorapanth, T Young
2015 Winter Simulation Conference (WSC), 1492-1502, 2015
92015
Microbial risk assessment for drinking water
SE Chick, S Soorapanth, JS Koopman
Operations Research and Health Care: A Handbook of Methods and Applications …, 2004
92004
Towards a framework for evaluating the costs and benefits of simulation modelling in healthcare
S Soorapanth, T Eldabi, T Young
Journal of the Operational Research Society 74 (3), 637-646, 2023
82023
The ASEAN blockchain roadmap
GR Ungson, S Soorapanth
Asia and the Global Economy 2 (3), 100047, 2022
72022
The contribution of the private sector to poverty alleviation programs: exploring business engagement in conditional cash transfers
GR Ungson, D Hudgens, MA Gonzalez-Perez, YY Wong, SA Wong, ...
Management Research: Journal of the Iberoamerican Academy of Management 21 …, 2023
62023
Simulation of stochastic infection transmission models designed to inform water treatment decisions
S Soorapanth, SE Chick, JS Koopman
Proceedings of the 13th European Simulation Symposium, 517-521, 2001
62001
Systems, design and value-for-money in the NHS: mission impossible?
T Young, A Morton, S Soorapanth
Future Healthcare Journal 5 (3), 156-159, 2018
52018
Cost-utility analysis of behavioral interventions for HIV-infected persons to reduce HIV transmission in the USA
S Soorapanth, SE Chick
Proceedings of the 2010 Winter Simulation Conference, 2433-2443, 2010
52010
Scheduling asset overhaul and repair services
PB Luh, S Soorapanth, DQ Yu, AI Khibnik
Proceedings of the 2003 NSF Design, Service and Manufacturing Grantees and …, 2003
52003
Comparative cost-efficacy analysis of darunavir/r and other ritonavir-boosted protease inhibitors for first-line treatment of HIV-1 infection in Germany
A Brogan, S Soorapanth, V Donatz, A Hill, E Smets
Value in Health 12 (7), A426, 2009
32009
The system can't perform the operation now. Try again later.
Articles 1–20